Current Size: 100%

Seminar Lectures 2018


Invited Speakers:


Prof. Dr. Hans-Uwe Simon (July 6th, 2018)           

Prof. Hans-Uwe Simon is Professor of Pharmacology at the University of Bern. Currently, he also serves as the Dean of the Faculty of Medicine at the University of Bern. He is also Editor-in-Chief of two journals: International Archives of Allergy and Immunology as well as Cell Death & Disease. Prof. Hans-Uwe Simon is interested in pathogenic mechanisms of eosinophilic diseases, such as hypereosinophilic syndromes (HES). On July 6th in 2018, he visited Prof. Peter Valent and his research team and gave an interesting talk about “Role of Eosinophils in HES and Related Conditions: Update 2018”.


Dr. Stefan Florian, PhD (May 8th, 2018)

It was a pleasure to welcome Dr. Stefan Florian from the Institute for Pathology at the Charité – Universitätsmedizin Berlin. He provided us an overview of microtubules in cancer therapy. The presentation was entitled “Cancer therapy and microtubules – how basic research and medicine collaborate but fail to communicate”. Dr. Stefan Florian did his postdoctoral fellowship at Havard Medical school, where his main research focused on the mechanism of action of microtubule binding drugs. Besides, he was one of the first students in the research group of Prof. Valent, where the main focus is on identifying potential drug targets in cancer stem cells of hematological malignancies.


Prof. Cem Akin (April 27th, 2018)

Professor Dr. Cem Akin held a talk entitled “Mast cell activation syndromes” where he gave a concise overview about rare condition termed as a mast cell activation syndrome (MCAS) and a less severe local form of MC activation (MCA). This lecture reviewed available diagnostic criteria and diagnostic tools that could be helpful for differential diagnoses of MCAS and MCA.


Prof. J.C. Hanneke Kluin-Nelemans (March 16th, 2018)

Prof. Kluin-Nelemans from the University of Groningen in the Netherlands visited us on March 16th in 2018 and talked about development and interventional drug therapies in mastocytosis. Her research focuses on the treatment of patients with advance systemic mastocytosis. In 2017, Prof. Hanneke Kluin-Nelemans was selected as researcher of the year and gold medal winner of the European Competence Network on Mastocytosis (ECNM).


Prof. Dr. Karin Hartmann (February 9th, 2018)

On 9th of February our cooperation partner Prof. Dr. Karin Hartmann joined us for a seminar lecture of the LBI-HO and SFBF47. Prof. Dr. Karin Hartmann is Professor of Allergology and Head of the Division of Allergy at the Department of Dermatology at the University Hospital Basel in Switzerland. The focus of her clinical research is mastocytosis, a rare disease characterized by a pathological proliferation of mast cells. Other specialties include urticaria, angioedema and atopic dermatitis. She is also a member of the European Competence Network on Mastocytosis (ECNM). Prof. Dr. Karin Hartmann gave a talk on clinical perspectives of midostaurin in mastocytosis. Afterwards, we had the opportunity to exchange and discuss.